16. Novel Therapies

Experience novel therapies in IBD, and of clinical trials used to pilot their introduction


Full content only available after log-in


16.1.  Understands the different types of evidence – clinical trial / cohort study / systematic review etc.

16.2.  Knows the evidence that supports the use of currently unlicensed therapies in IBD


        
 
Topic:


Programme Phase:



Content Format:








Page: () 1 2 3

Topic 16.2 : State of the art

Anti IL12/IL23 compounds

B Sands

ECCO 2017 Barcelona Congress

Webcast + PPT
 


Topic 16.1 :

Monitoring and improving safety of new agents

M. Regueiro

ECCO'18 Vienna

Webcast + PPT
 


Topic 16.1, 16.2 :

Medical treatment

K. Katsanos

ECCO'18 Vienna

PPT
 


Topic 16.1, 16.2 :

When approved drugs dont work

D. Wilson

ECCO'18 Vienna

PPT
 


Topic 16.2 :

A case for and against oral iron in IBD: Tandem talk

C. Lees

ECCO'18 Vienna

PPT
 


Topic 16.2 :

Abstract 5: Targeting fibroblast activation protein in Crohn's Disease intestinal strictures restores balanced deposition of extracellular matrix and reduces fibrosis

M. Truffi

ECCO'18 Vienna

PPT
 


Topic 16.2 :

Hot cells in IBD

M. Wildenberg

ECCO'18 Vienna

PPT
 


Topic 16.2 :

Small molecules are back

L. Peyrin-Biroulet

ECCO'18 Vienna

Webcast + PPT
 


Topic 16.2 :

Stem cell therapy for perianal CD multidisciplinary management

D. Garca-Olmo, S. Danese

ECCO'18 Vienna

Webcast + PPT
 


Topic 16.2 :

Tofacitinib

S. Vermeire

ECCO'18 Vienna

PPT
 


Page: () 1 2 3